Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-09-12

Clinical Trial Update: Investigating the Novel Observation of Right-left Difference in Uterine Artery Vascular Resistance in Pre-eclampsia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating uterine artery vascular resistance in pre-eclampsia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Pre-eclampsia | Phase 3 | Status: WITHDRAWN